Concepedia

Efficacy and safety of tabalumab, an anti-B-cell-activating factor monoclonal antibody, in patients with rheumatoid arthritis who had an inadequate response to methotrexate therapy: results from a phase III multicentre, randomised, double-blind study

Josef S Smolen, Michael E. Weinblatt, Désirée van der Heijde, William F. C. Rigby, Ronald van Vollenhoven, Clifton O. Bingham, Melissa Veenhuizen, Anne Gill, Fangyi Zhao, Wendy Komocsar,

Annals of the Rheumatic Diseases · 2015 · 34 citations · 8 references

DOI

Concepts

References

8

How to read radiographs according to the Sharp/van der Heijde method.

D. van der Heijde · PubMed · 1999 · 1.2K citations

, , +14

Atacicept in patients with rheumatoid arthritis and an inadequate response to methotrexate: Results of a phase II, randomized, placebo-controlled trial

Ronald van Vollenhoven, Nils Kinnman, Emmanuelle Vincent et al. · Arthritis & Rheumatism · 2011 · 168 citations

, , +16

Atacicept in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor antagonist therapy: Results of a phase II, randomized, placebo-controlled, dose-finding trial

Mark C. Genovese, Nils Kinnman, Guillaume de La Bourdonnaye et al. · Arthritis & Rheumatism · 2011 · 122 citations

, , +13

Efficacy and Safety of Belimumab in Patients with Rheumatoid Arthritis: A Phase II, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study

William Stohl, Joan T. Merrill, James D. McKay et al. · The Journal of Rheumatology · 2013 · 97 citations · Full text

, , +13

Tabalumab in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate and Naive to Biologic Therapy: A Phase II, Randomized, Placebo‐Controlled Trial

Mark C. Genovese, S. Bojin, Ilaria Biagini et al. · Arthritis & Rheumatism · 2013 · 69 citations

, , +15